Bo Du

Yaowei Bai, Ruiheng Zhang, Yu Lei et al.

A global shortage of radiologists has been exacerbated by the significant volume of chest X-ray workloads, particularly in primary care. Although multimodal large language models show promise, existing evaluations predominantly rely on automated metrics or retrospective analyses, lacking rigorous prospective clinical validation. Janus-Pro-CXR (1B), a chest X-ray interpretation system based on DeepSeek Janus-Pro model, was developed and rigorously validated through a multicenter prospective trial (NCT07117266). Our system outperforms state-of-the-art X-ray report generation models in automated report generation, surpassing even larger-scale models including ChatGPT 4o (200B parameters), while demonstrating reliable detection of six clinically critical radiographic findings. Retrospective evaluation confirms significantly higher report accuracy than Janus-Pro and ChatGPT 4o. In prospective clinical deployment, AI assistance significantly improved report quality scores, reduced interpretation time by 18.3% (P < 0.001), and was preferred by a majority of experts in 54.3% of cases. Through lightweight architecture and domain-specific optimization, Janus-Pro-CXR improves diagnostic reliability and workflow efficiency, particularly in resource-constrained settings. The model architecture and implementation framework will be open-sourced to facilitate the clinical translation of AI-assisted radiology solutions.

Kun Li, Yong Luo, Xiantao Cai et al.

Conventional deep learning methods typically employ supervised learning for drug response prediction (DRP). This entails dependence on labeled response data from drugs for model training. However, practical applications in the preclinical drug screening phase demand that DRP models predict responses for novel compounds, often with unknown drug responses. This presents a challenge, rendering supervised deep learning methods unsuitable for such scenarios. In this paper, we propose a zero-shot learning solution for the DRP task in preclinical drug screening. Specifically, we propose a Multi-branch Multi-Source Domain Adaptation Test Enhancement Plug-in, called MSDA. MSDA can be seamlessly integrated with conventional DRP methods, learning invariant features from the prior response data of similar drugs to enhance real-time predictions of unlabeled compounds. We conducted experiments using the GDSCv2 and CellMiner datasets. The results demonstrate that MSDA efficiently predicts drug responses for novel compounds, leading to a general performance improvement of 5-10\% in the preclinical drug screening phase. The significance of this solution resides in its potential to accelerate the drug discovery process, improve drug candidate assessment, and facilitate the success of drug discovery.

Weihao Xuan, Qingcheng Zeng, Heli Qi et al.

Autonomous agents based on large language models (LLMs) are rapidly evolving to handle multi-turn tasks, but ensuring their trustworthiness remains a critical challenge. A fundamental pillar of this trustworthiness is calibration, which refers to an agent's ability to express confidence that reliably reflects its actual performance. While calibration is well-established for static models, its dynamics in tool-integrated agentic workflows remain underexplored. In this work, we systematically investigate verbalized calibration in tool-use agents, revealing a fundamental confidence dichotomy driven by tool type. Specifically, our pilot study identifies that evidence tools (e.g., web search) systematically induce severe overconfidence due to inherent noise in retrieved information, while verification tools (e.g., code interpreters) can ground reasoning through deterministic feedback and mitigate miscalibration. To robustly improve calibration across tool types, we propose a reinforcement learning (RL) fine-tuning framework that jointly optimizes task accuracy and calibration, supported by a holistic benchmark of reward designs. We demonstrate that our trained agents not only achieve superior calibration but also exhibit robust generalization from local training environments to noisy web settings and to distinct domains such as mathematical reasoning. Our results highlight the necessity of domain-specific calibration strategies for tool-use agents. More broadly, this work establishes a foundation for building self-aware agents that can reliably communicate uncertainty in high-stakes, real-world deployments.

Hang Chen, Maoyuan Ye, Peng Yang et al.

Power transmission corridor hazard segmentation (PTCHS) aims to separate transmission equipment and surrounding hazards from complex background, conveying great significance to maintaining electric power transmission safety. Recently, the Segment Anything Model (SAM) has emerged as a foundational vision model and pushed the boundaries of segmentation tasks. However, SAM struggles to deal with the target objects in complex transmission corridor scenario, especially those with fine structure. In this paper, we propose ELE-SAM, adapting SAM for the PTCHS task. Technically, we develop a Context-Aware Prompt Adapter to achieve better prompt tokens via incorporating global-local features and focusing more on key regions. Subsequently, to tackle the hazard objects with fine structure in complex background, we design a High-Fidelity Mask Decoder by leveraging multi-granularity mask features and then scaling them to a higher resolution. Moreover, to train ELE-SAM and advance this field, we construct the ELE-40K benchmark, the first large-scale and real-world dataset for PTCHS including 44,094 image-mask pairs. Experimental results for ELE-40K demonstrate the superior performance that ELE-SAM outperforms the baseline model with the average 16.8% mIoU and 20.6% mBIoU performance improvement. Moreover, compared with the state-of-the-art method on HQSeg-44K, the average 2.9% mIoU and 3.8% mBIoU absolute improvements further validate the effectiveness of our method on high-quality generic object segmentation. The source code and dataset are available at https://github.com/Hhaizee/ELE-SAM.

Ziyang Gong, Zhixiang Wei, Di Wang et al.

The field of Remote Sensing Domain Generalization (RSDG) has emerged as a critical and valuable research frontier, focusing on developing models that generalize effectively across diverse scenarios. Despite the substantial domain gaps in RS images that are characterized by variabilities such as location, wavelength, and sensor type, research in this area remains underexplored: (1) Current cross-domain methods primarily focus on Domain Adaptation (DA), which adapts models to predefined domains rather than to unseen ones; (2) Few studies targeting the RSDG issue, especially for semantic segmentation tasks, where existing models are developed for specific unknown domains, struggling with issues of underfitting on other unknown scenarios; (3) Existing RS foundation models tend to prioritize in-domain performance over cross-domain generalization. To this end, we introduce the first vision foundation model for RSDG semantic segmentation, CrossEarth. CrossEarth demonstrates strong cross-domain generalization through a specially designed data-level Earth-Style Injection pipeline and a model-level Multi-Task Training pipeline. In addition, for the semantic segmentation task, we have curated an RSDG benchmark comprising 32 cross-domain settings across various regions, spectral bands, platforms, and climates, providing a comprehensive framework for testing the generalizability of future RSDG models. Extensive experiments on this benchmark demonstrate the superiority of CrossEarth over existing state-of-the-art methods.

Kun Li, Yida Xiong, Hongzhi Zhang et al.

Due to their excellent drug-like and pharmacokinetic properties, small molecule drugs are widely used to treat various diseases, making them a critical component of drug discovery. In recent years, with the rapid development of deep learning (DL) techniques, DL-based small molecule drug discovery methods have achieved excellent performance in prediction accuracy, speed, and complex molecular relationship modeling compared to traditional machine learning approaches. These advancements enhance drug screening efficiency and optimization and provide more precise and effective solutions for various drug discovery tasks. Contributing to this field's development, this paper aims to systematically summarize and generalize the recent key tasks and representative techniques in graph-structured small molecule drug discovery in recent years. Specifically, we provide an overview of the major tasks in small molecule drug discovery and their interrelationships. Next, we analyze the six core tasks, summarizing the related methods, commonly used datasets, and technological development trends. Finally, we discuss key challenges, such as interpretability and out-of-distribution generalization, and offer our insights into future research directions for small molecule drug discovery.